Dr. Donna M. Bouley currently working as a Professor of Comparative Medicine, by courtesy, of Pathology at the Stanford University Medical Center and as a Member of Stanford Cancer Institute. She has provided pathology support for several Stanford radiologists using MRI-guided minimally-invasive therapies for the ablation of prostate cancer (focused ultrasound, cryoablation, laser). Histopathological evaluation of induced lesions provides the radiologists with feedback necessary to optimize their procedures, and interpret real-time MR images in order to guarantee the most effective cancer treatment. She also work with several radiation oncologists who study and test hypoxic cytotoxic drugs as cancer treatments.

Her research interests are quite varied. She provide pathology support for several Stanford radiologists using MRI-guided minimally-invasive therapies for the ablation of prostate cancer (focused ultrasound, cryoablation, laser). Histopathological evaluation of induced lesions provides the radiologists with feedback necessary to optimize their procedures, and interpret real-time MR images in order to guarantee the most effective cancer treatment. She also work with several radiation oncologists who study and test hypoxic cytotoxic drugs as cancer treatments. Other interests of her include phenotypic analysis of transgenic and knockout mice, the use of genetically engineered mice to understand host pathogen interactions, and infectious diseases of frogs.